May 30, 2026 - 02:29

Piper Sandler has reaffirmed its Overweight rating on Corebridge Financial (CRBG) even as it lowered the price target for the stock. The firm reduced its target to $31 from $35, citing recent stock performance as the main reason for the adjustment. Despite the lower target, analysts remain positive on the company's outlook and believe the shares still offer value at current levels.
The revised price target comes as Corebridge Financial continues to be a notable holding in major investment portfolios. The company is included among billionaire George Soros's stock picks, specifically listed in the top 10 stocks to buy within his portfolio. This inclusion highlights the stock's appeal to high-profile investors who see long-term potential in the insurance and financial services sector.
Corebridge Financial, which trades under the ticker CRBG on the New York Stock Exchange, has been navigating a shifting market environment. Piper Sandler's decision to maintain an Overweight rating suggests that the firm expects the company to outperform its peers or the broader market over time. The lowered price target appears to be a tactical adjustment rather than a sign of fundamental weakness.
Investors are watching the stock closely as it balances short-term price movements against the backing of influential investors and positive analyst sentiment. The reaffirmed rating provides some confidence, though the reduced target indicates a more cautious near-term outlook.
August 28, 2026 - 04:10
Michael Burry Thanks Tech Columnist’s Praise For Making ‘A Killing’ On NVDA, MSFT Calls Into EarningsInvestor Michael Burry, best known for betting against the housing market before the 2008 crash, has acknowledged a tech columnist`s compliment about his recent options trades. The acknowledgment...
August 27, 2026 - 21:27
Texas is on RBC's map to grow its City National Bank unitRoyal Bank of Canada is setting its sights on Texas as a key market for expanding its City National Bank subsidiary. Senior executives at the Toronto-based lender said they see strong organic...
August 27, 2026 - 11:07
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate UpdatesShanghai, August 26, 2026 - Shanghai Junshi Biosciences, a biopharmaceutical company focused on creating new treatments, has shared its financial results for the first half of 2026. The company...
August 26, 2026 - 19:37
OverActive Media Reports Second Quarter 2026 Results; Operating Expenses Narrow 17%, Gross Margin Expands to 52% Year-to-DateOverActive Media Corp. has released its financial results for the three and six months ending June 30, 2026, showing meaningful progress on operational efficiency. The company, which owns and...